Antengene Announces First Patient Dosed in Phase II Trial of ATG-008 (Onatasertib) in Patients with Advanced Solid Tumors with Specific Genetic Alterations Read more
Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference Read more
Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company ahead of Pain Therapeutics Read more
Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib Read more
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients Read more
Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program Read more
AbbVie Submits Regulatory Applications for SKYRIZI (risankizumab) in Psoriatic Arthritis to FDA and EMA Read more